
Estradiol Cypionate
Estradiol Cypionate (CAS No: 313-06-4) is produced by Amber Lifesciences Pvt. Ltd. in GMP and ISO 9001:2015 certified facilities, ensuring premium purity, stability, and compliance with BP and USP pharmacopeial standards. This high-quality API is supplied with a Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) to support regulatory submissions and quality assurance requirements.
Primarily used in hormone replacement therapy (HRT) for estrogen deficiency and menopausal symptom management, Estradiol Cypionate is formulated in injectable dosage forms. Each batch is rigorously tested for consistency, traceability, and global compliance, making it suitable for regulated markets.
Amber Lifesciences supports pharmaceutical manufacturers, importers, and traders across LATAM, Asia, Europe, and the Middle East, offering reliable supply, transparent service, and robust technical and regulatory documentation to facilitate both evaluation and commercial-scale production.
Storage & Transportation:
This product is classified as non-Dangerous Goods. Store at 20°C to 25°C (68°F to 77°F), protected from light and moisture. Handle with standard storage protocols to maintain integrity.
CAS No.: | 313-06-4 |
|---|---|
Synonym: | Depofemin, Depoestradiol, Depo-Estradiol |
Mol. formula: | C₂₆H₃₆O₃ |
Mol. Weight: | 396.6 g/mol |
Active Pharmaceutical Ingredient (API) – Not for Direct Human or Veterinary Use.